Correlation Between PTC Therapeutics and Day One
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Day One Biopharmaceuticals, you can compare the effects of market volatilities on PTC Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Day One.
Diversification Opportunities for PTC Therapeutics and Day One
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between PTC and Day is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Day One go up and down completely randomly.
Pair Corralation between PTC Therapeutics and Day One
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 1.14 times more return on investment than Day One. However, PTC Therapeutics is 1.14 times more volatile than Day One Biopharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 3,992 in PTC Therapeutics on September 1, 2024 and sell it today you would earn a total of 396.00 from holding PTC Therapeutics or generate 9.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PTC Therapeutics vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| PTC Therapeutics |
| Day One Biopharmaceu |
PTC Therapeutics and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PTC Therapeutics and Day One
The main advantage of trading using opposite PTC Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
| Day One vs. Cue Biopharma | Day One vs. Tff Pharmaceuticals | Day One vs. Lantern Pharma | Day One vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |